United States Biotechnology & Medical Research

Exact Sciences Corp (EXAS)

Track

Track

Ticker: EXAS Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Exact Sciences Corp. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
ORVILLE JACOB A EVP, GM, Screening Officer
Transaction date
Planned sale
Price
84.18
Quantity 30,956 -7.1%
Value US$3,457,588
Herriott James SVP, General Counsel & Sec Officer
Transaction date
Planned sale
Price
246.76
Quantity 55,929 -16.0%
Value US$2,118,877
ORVILLE JACOB A Officer Officer
Transaction date
Proposed sale
Price
274.58
Quantity 69,540
Value US$3,957,908
Herriott James Officer Officer
Transaction date
Proposed sale
Price
70.00
Quantity 1,000
Value US$70,000
Baranick Brian EVP, GM, Precision Oncology Officer
Transaction date
Planned sale
Price
70.08
Quantity 2,858 -11.3%
Value US$200,289
Herriott James SVP, General Counsel & Sec Officer
Transaction date
Planned sale
Price
70.08
Quantity 1,500 -10.6%
Value US$105,120
Baranick Brian Officer Officer
Transaction date
Proposed sale
Price
70.08
Quantity 2,858
Value US$200,289
Herriott James Officer Officer
Transaction date
Proposed sale
Price
70.08
Quantity 1,500
Value US$105,120
3.8
Zanotti Katherine S Non-Executive Director
Transaction date
Planned sale
Price
65.00
Quantity 12,000 -16.5%
Value US$780,000
3.8
Zanotti Katherine S Director Non-Executive Director
Transaction date
Proposed sale
Price
65.00
Quantity 12,000
Value US$780,000
Herriott James SVP, General Counsel & Sec Officer
Transaction date
Planned sale
Price
60.00
Quantity 1,500 -9.6%
Value US$90,000
Doyle James Edward Non-Executive Director
Transaction date
Planned sale
Price
60.00
Quantity 2,000 -3.3%
Value US$120,000
Herriott James Officer Officer
Transaction date
Proposed sale
Price
60.00
Quantity 1,500
Value US$90,000
Doyle James Edward Director Non-Executive Director
Transaction date
Proposed sale
Price
60.00
Quantity 2,000
Value US$120,000
Doyle James Edward Non-Executive Director
Transaction date
Planned sale
Price
42.02
Quantity 1,485 -2.4%
Value US$62,400
Doyle James Edward Director Non-Executive Director
Transaction date
Proposed sale
Price
42.02
Quantity 1,485
Value US$62,400
3.0
Sebelius Kathleen Former Director Non-Executive Director
Transaction date
Proposed sale
Price
53.11
Quantity 8,164
Value US$433,605
3.8
Zanotti Katherine S Non-Executive Director
Transaction date
Planned sale
Price
53.20
Quantity 3,207 -4.2%
Value US$170,612
3.8
Zanotti Katherine S Director Non-Executive Director
Transaction date
Proposed sale
Price
53.20
Quantity 3,207
Value US$170,612
1.8
Conroy Kevin T President and CEO Executive Director
Transaction date
Purchase
Price
51.35
Quantity 19,500 +1.8%
Value US$1,001,325
Baranick Brian EVP, GM, Precision Oncology Officer
Transaction date
Planned sale
Price
70.00
Quantity 929 -6.8%
Value US$65,030
Baranick Brian Officer Officer
Transaction date
Proposed sale
Price
70.00
Quantity 929
Value US$65,030
Baranick Brian EVP, GM, Precision Oncology Officer
Transaction date
Planned sale
Price
70.00
Quantity 929 -6.4%
Value US$65,030
Baranick Brian Officer Officer
Transaction date
Proposed sale
Price
70.00
Quantity 929
Value US$65,030
1.8
Conroy Kevin T President and CEO Executive Director
Transaction date
Planned sale
Price
60.15
Quantity 1,155 -0.1%
Value US$69,473
1.8
Conroy Kevin T President and CEO Executive Director
Transaction date
Planned sale
Price
60.15
Quantity 1,155 -0.1%
Value US$69,473
Baranick Brian EVP, GM., Precision Oncology Officer
Transaction date
Planned sale
Price
60.15
Quantity 110 -0.8%
Value US$6,616
Baranick Brian EVP, GM., Precision Oncology Officer
Transaction date
Planned sale
Price
60.15
Quantity 110 -0.8%
Value US$6,616
ORVILLE JACOB A General Manager, Screening Officer
Transaction date
Planned sale
Price
60.15
Quantity 102 -0.7%
Value US$6,135
ORVILLE JACOB A General Manager, Screening Officer
Transaction date
Planned sale
Price
60.15
Quantity 102 -0.7%
Value US$6,135
1.5
Elliott Jeffrey Thomas Chief Financial Officer Officer
Transaction date
Planned sale
Price
60.15
Quantity 136 -1.1%
Value US$8,180
1.5
Elliott Jeffrey Thomas Chief Financial Officer Officer
Transaction date
Planned sale
Price
60.15
Quantity 136 -1.1%
Value US$8,180
3.0
Condella Sarah EVP, Human Resources Officer
Transaction date
Planned sale
Price
60.15
Quantity 102 -0.1%
Value US$6,135
COWARD D SCOTT Non-Executive Director
Transaction date
Planned sale
Price
60.15
Quantity 67 -0.1%
Value US$4,030
Herriott James SVP, General Counsel & Sec Officer
Transaction date
Planned sale
Price
60.15
Quantity 30 -0.3%
Value US$1,804
2.9
Cunningham Everett Chief Commercial Officer Officer
Transaction date
Planned sale
Price
60.15
Quantity 136 -0.3%
Value US$8,180
1.5
Elliott Jeffrey Thomas Officer Officer
Transaction date
Proposed sale
Price
60.15
Quantity 136
Value US$8,180
COWARD D SCOTT Director Non-Executive Director
Transaction date
Proposed sale
Price
60.15
Quantity 67
Value US$4,030
2.9
Cunningham Everett Officer Officer
Transaction date
Proposed sale
Price
60.15
Quantity 136
Value US$8,180
3.0
Condella Sarah Officer Officer
Transaction date
Proposed sale
Price
60.15
Quantity 102
Value US$6,135
1.8
Conroy Kevin T Officer; Director Executive Director
Transaction date
Proposed sale
Price
60.15
Quantity 1,155
Value US$69,473
ORVILLE JACOB A Officer Officer
Transaction date
Proposed sale
Price
60.15
Quantity 102
Value US$6,135
Baranick Brian Officer Officer
Transaction date
Proposed sale
Price
60.15
Quantity 110
Value US$6,616
Herriott James Officer Officer
Transaction date
Proposed sale
Price
60.15
Quantity 30
Value US$1,804
Baranick Brian EVP, GM., Precision Oncology Officer
Transaction date
Planned sale
Price
79.43
Quantity 924 -6.6%
Value US$73,393
Baranick Brian Officer Officer
Transaction date
Proposed sale
Price
79.43
Quantity 924
Value US$73,393
3.0
Condella Sarah EVP, Human Resources Officer
Transaction date
Planned sale
Price
70.00
Quantity 2,000 -2.7%
Value US$140,000
3.0
Condella Sarah Officer Officer
Transaction date
Proposed sale
Price
70.00
Quantity 2,000
Value US$140,000
3.0
Condella Sarah EVP, Human Resources Officer
Transaction date
Planned sale
Price
70.00
Quantity 2,000 -2.6%
Value US$140,000
3.0
Condella Sarah Officer Officer
Transaction date
Proposed sale
Price
70.00
Quantity 2,000
Value US$140,000
ORVILLE JACOB A General Manager, Screening Officer
Transaction date
Planned sale
Price
59.32
Quantity 2,154 -13.1%
Value US$127,775
Herriott James General Counsel Officer
Transaction date
Planned sale
Price
59.32
Quantity 862 -8.6%
Value US$51,134
1.8
Conroy Kevin T President and CEO Executive Director
Transaction date
Planned sale
Price
59.32
Quantity 8,271 -0.6%
Value US$490,636
1.5
Elliott Jeffrey Thomas Chief Financial Officer Officer
Transaction date
Planned sale
Price
59.32
Quantity 2,412 -18.1%
Value US$143,080
2.9
Cunningham Everett Chief Commercial Officer Officer
Transaction date
Planned sale
Price
59.32
Quantity 2,412 -5.0%
Value US$143,080
Doyle James Edward Non-Executive Director
Transaction date
Planned sale
Price
57.50
Quantity 2,000 -3.8%
Value US$115,000
Baranick Brian Gen. Mgr., Precision Oncology Officer
Transaction date
Planned sale
Price
59.32
Quantity 2,323 -14.1%
Value US$137,800
LEVANGIE DANIEL J Non-Executive Director
Transaction date
Planned sale
Price
57.50
Quantity 5,000 -17.9%
Value US$287,500
3.0
Condella Sarah EVP, Human Resources Officer
Transaction date
Planned sale
Price
59.32
Quantity 1,724 -2.2%
Value US$102,268
2.9
Cunningham Everett Officer Officer
Transaction date
Proposed sale
Price
59.32
Quantity 2,412
Value US$143,078
Herriott James Officer Officer
Transaction date
Proposed sale
Price
59.32
Quantity 862
Value US$51,133
3.0
Condella Sarah Officer Officer
Transaction date
Proposed sale
Price
59.32
Quantity 1,724
Value US$102,266
1.5
Elliott Jeffrey Thomas Officer Officer
Transaction date
Proposed sale
Price
59.32
Quantity 2,412
Value US$143,078
ORVILLE JACOB A Officer Officer
Transaction date
Proposed sale
Price
59.32
Quantity 2,154
Value US$127,773
Baranick Brian Officer Officer
Transaction date
Proposed sale
Price
59.32
Quantity 2,323
Value US$137,798
1.8
Conroy Kevin T Officer; Director Executive Director
Transaction date
Proposed sale
Price
59.32
Quantity 8,271
Value US$490,628
Doyle James Edward Director Non-Executive Director
Transaction date
Proposed sale
Price
57.50
Quantity 2,000
Value US$115,000
LEVANGIE DANIEL J Director Non-Executive Director
Transaction date
Proposed sale
Price
57.50
Quantity 5,000
Value US$287,500
3.0
Condella Sarah EVP, Human Resources Officer
Transaction date
Planned sale
Price
56.89
Quantity 1,880 -2.5%
Value US$106,953
ORVILLE JACOB A General Manager, Screening Officer
Transaction date
Planned sale
Price
56.89
Quantity 1,879 -13.8%
Value US$106,896
Baranick Brian Gen. Mgr., Precision Oncology Officer
Transaction date
Planned sale
Price
56.89
Quantity 2,027 -14.8%
Value US$115,316
Herriott James General Counsel Officer
Transaction date
Planned sale
Price
56.89
Quantity 784 -8.8%
Value US$44,602
1.8
Conroy Kevin T President and CEO Executive Director
Transaction date
Planned sale
Price
56.89
Quantity 6,263 -0.5%
Value US$356,302
2.9
Cunningham Everett Chief Commercial Officer Officer
Transaction date
Planned sale
Price
56.89
Quantity 3,648 -7.8%
Value US$207,535
1.5
Elliott Jeffrey Thomas Chief Financial Officer Officer
Transaction date
Planned sale
Price
56.89
Quantity 2,710 -25.2%
Value US$154,172
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2025-11-21 2025-11-19 PlS Planned sale
ORVILLE JACOB A

EVP, GM, Screening

Officer
30,956 -7.1%
84.18
US$3,457,588 		30,956 -7.1% 84.18 US$3,457,588
2025-11-21 2025-11-19 PlS Planned sale
Herriott James

SVP, General Counsel & Sec

Officer
55,929 -16.0%
246.76
US$2,118,877 		55,929 -16.0% 246.76 US$2,118,877
2025-11-19 2025-11-19 PrS Proposed sale
ORVILLE JACOB A

Officer

Officer
69,540
274.58
US$3,957,908 		69,540 274.58 US$3,957,908
2025-11-19 2025-11-19 PrS Proposed sale
Herriott James

Officer

Officer
1,000
70.00
US$70,000 		1,000 70.00 US$70,000
2025-11-06 2025-11-04 PlS Planned sale
Baranick Brian

EVP, GM, Precision Oncology

Officer
2,858 -11.3%
70.08
US$200,289 		2,858 -11.3% 70.08 US$200,289
2025-11-06 2025-11-04 PlS Planned sale
Herriott James

SVP, General Counsel & Sec

Officer
1,500 -10.6%
70.08
US$105,120 		1,500 -10.6% 70.08 US$105,120
2025-11-04 2025-11-04 PrS Proposed sale
Baranick Brian

Officer

Officer
2,858
70.08
US$200,289 		2,858 70.08 US$200,289
2025-11-04 2025-11-04 PrS Proposed sale
Herriott James

Officer

Officer
1,500
70.08
US$105,120 		1,500 70.08 US$105,120
2025-10-27 2025-10-24 PlS Planned sale
3.8
Zanotti Katherine S
Non-Executive Director
12,000 -16.5%
65.00
US$780,000 		12,000 -16.5% 65.00 US$780,000
2025-10-24 2025-10-24 PrS Proposed sale
3.8
Zanotti Katherine S

Director

Non-Executive Director
12,000
65.00
US$780,000 		12,000 65.00 US$780,000
2025-10-10 2025-10-09 PlS Planned sale
Herriott James

SVP, General Counsel & Sec

Officer
1,500 -9.6%
60.00
US$90,000 		1,500 -9.6% 60.00 US$90,000
2025-10-10 2025-10-09 PlS Planned sale
Doyle James Edward
Non-Executive Director
2,000 -3.3%
60.00
US$120,000 		2,000 -3.3% 60.00 US$120,000
2025-10-09 2025-10-09 PrS Proposed sale
Herriott James

Officer

Officer
1,500
60.00
US$90,000 		1,500 60.00 US$90,000
2025-10-09 2025-10-09 PrS Proposed sale
Doyle James Edward

Director

Non-Executive Director
2,000
60.00
US$120,000 		2,000 60.00 US$120,000
2025-08-14 2025-08-13 PlS Planned sale
Doyle James Edward
Non-Executive Director
1,485 -2.4%
42.02
US$62,400 		1,485 -2.4% 42.02 US$62,400
2025-08-13 2025-08-13 PrS Proposed sale
Doyle James Edward

Director

Non-Executive Director
1,485
42.02
US$62,400 		1,485 42.02 US$62,400
2025-07-16 2025-07-16 PrS Proposed sale
3.0
Sebelius Kathleen

Former Director

Non-Executive Director
8,164
53.11
US$433,605 		8,164 53.11 US$433,605
2025-06-16 2025-06-13 PlS Planned sale
3.8
Zanotti Katherine S
Non-Executive Director
3,207 -4.2%
53.20
US$170,612 		3,207 -4.2% 53.20 US$170,612
2025-06-13 2025-06-13 PrS Proposed sale
3.8
Zanotti Katherine S

Director

Non-Executive Director
3,207
53.20
US$170,612 		3,207 53.20 US$170,612
2024-11-13 2024-11-13 B Purchase
1.8
Conroy Kevin T

President and CEO

Executive Director
19,500 +1.8%
51.35
US$1,001,325 		19,500 +1.8% 51.35 US$1,001,325
2024-10-09 2024-10-08 PlS Planned sale
Baranick Brian

EVP, GM, Precision Oncology

Officer
929 -6.8%
70.00
US$65,030 		929 -6.8% 70.00 US$65,030
2024-10-08 2024-10-08 PrS Proposed sale
Baranick Brian

Officer

Officer
929
70.00
US$65,030 		929 70.00 US$65,030
2024-09-19 2024-09-18 PlS Planned sale
Baranick Brian

EVP, GM, Precision Oncology

Officer
929 -6.4%
70.00
US$65,030 		929 -6.4% 70.00 US$65,030
2024-09-18 2024-09-18 PrS Proposed sale
Baranick Brian

Officer

Officer
929
70.00
US$65,030 		929 70.00 US$65,030
2024-05-02 2024-05-01 PlS Planned sale
1.8
Conroy Kevin T

President and CEO

Executive Director
1,155 -0.1%
60.15
US$69,473 		1,155 -0.1% 60.15 US$69,473
2024-05-02 2024-05-01 PlS Planned sale
1.8
Conroy Kevin T

President and CEO

Executive Director
1,155 -0.1%
60.15
US$69,473 		1,155 -0.1% 60.15 US$69,473
2024-05-02 2024-05-01 PlS Planned sale
Baranick Brian

EVP, GM., Precision Oncology

Officer
110 -0.8%
60.15
US$6,616 		110 -0.8% 60.15 US$6,616
2024-05-02 2024-05-01 PlS Planned sale
Baranick Brian

EVP, GM., Precision Oncology

Officer
110 -0.8%
60.15
US$6,616 		110 -0.8% 60.15 US$6,616
2024-05-02 2024-05-01 PlS Planned sale
ORVILLE JACOB A

General Manager, Screening

Officer
102 -0.7%
60.15
US$6,135 		102 -0.7% 60.15 US$6,135
2024-05-02 2024-05-01 PlS Planned sale
ORVILLE JACOB A

General Manager, Screening

Officer
102 -0.7%
60.15
US$6,135 		102 -0.7% 60.15 US$6,135
2024-05-02 2024-05-01 PlS Planned sale
1.5
Elliott Jeffrey Thomas

Chief Financial Officer

Officer
136 -1.1%
60.15
US$8,180 		136 -1.1% 60.15 US$8,180
2024-05-02 2024-05-01 PlS Planned sale
1.5
Elliott Jeffrey Thomas

Chief Financial Officer

Officer
136 -1.1%
60.15
US$8,180 		136 -1.1% 60.15 US$8,180
2024-05-02 2024-05-01 PlS Planned sale
3.0
Condella Sarah

EVP, Human Resources

Officer
102 -0.1%
60.15
US$6,135 		102 -0.1% 60.15 US$6,135
2024-05-02 2024-05-01 PlS Planned sale
COWARD D SCOTT
Non-Executive Director
67 -0.1%
60.15
US$4,030 		67 -0.1% 60.15 US$4,030
2024-05-02 2024-05-01 PlS Planned sale
Herriott James

SVP, General Counsel & Sec

Officer
30 -0.3%
60.15
US$1,804 		30 -0.3% 60.15 US$1,804
2024-05-02 2024-05-01 PlS Planned sale
2.9
Cunningham Everett

Chief Commercial Officer

Officer
136 -0.3%
60.15
US$8,180 		136 -0.3% 60.15 US$8,180
2024-05-01 2024-05-01 PrS Proposed sale
1.5
Elliott Jeffrey Thomas

Officer

Officer
136
60.15
US$8,180 		136 60.15 US$8,180
2024-05-01 2024-05-01 PrS Proposed sale
COWARD D SCOTT

Director

Non-Executive Director
67
60.15
US$4,030 		67 60.15 US$4,030
2024-05-01 2024-05-01 PrS Proposed sale
2.9
Cunningham Everett

Officer

Officer
136
60.15
US$8,180 		136 60.15 US$8,180
2024-05-01 2024-05-01 PrS Proposed sale
3.0
Condella Sarah

Officer

Officer
102
60.15
US$6,135 		102 60.15 US$6,135
2024-05-01 2024-05-01 PrS Proposed sale
1.8
Conroy Kevin T

Officer; Director

Executive Director
1,155
60.15
US$69,473 		1,155 60.15 US$69,473
2024-05-01 2024-05-01 PrS Proposed sale
ORVILLE JACOB A

Officer

Officer
102
60.15
US$6,135 		102 60.15 US$6,135
2024-05-01 2024-05-01 PrS Proposed sale
Baranick Brian

Officer

Officer
110
60.15
US$6,616 		110 60.15 US$6,616
2024-05-01 2024-05-01 PrS Proposed sale
Herriott James

Officer

Officer
30
60.15
US$1,804 		30 60.15 US$1,804
2024-04-03 2024-04-02 PlS Planned sale
Baranick Brian

EVP, GM., Precision Oncology

Officer
924 -6.6%
79.43
US$73,393 		924 -6.6% 79.43 US$73,393
2024-04-02 2024-04-02 PrS Proposed sale
Baranick Brian

Officer

Officer
924
79.43
US$73,393 		924 79.43 US$73,393
2024-04-03 2024-04-01 PlS Planned sale
3.0
Condella Sarah

EVP, Human Resources

Officer
2,000 -2.7%
70.00
US$140,000 		2,000 -2.7% 70.00 US$140,000
2024-04-01 2024-04-01 PrS Proposed sale
3.0
Condella Sarah

Officer

Officer
2,000
70.00
US$140,000 		2,000 70.00 US$140,000
2024-04-01 2024-03-28 PlS Planned sale
3.0
Condella Sarah

EVP, Human Resources

Officer
2,000 -2.6%
70.00
US$140,000 		2,000 -2.6% 70.00 US$140,000
2024-03-28 2024-03-28 PrS Proposed sale
3.0
Condella Sarah

Officer

Officer
2,000
70.00
US$140,000 		2,000 70.00 US$140,000
2024-03-04 2024-03-01 PlS Planned sale
ORVILLE JACOB A

General Manager, Screening

Officer
2,154 -13.1%
59.32
US$127,775 		2,154 -13.1% 59.32 US$127,775
2024-03-04 2024-03-01 PlS Planned sale
Herriott James

General Counsel

Officer
862 -8.6%
59.32
US$51,134 		862 -8.6% 59.32 US$51,134
2024-03-04 2024-03-01 PlS Planned sale
1.8
Conroy Kevin T

President and CEO

Executive Director
8,271 -0.6%
59.32
US$490,636 		8,271 -0.6% 59.32 US$490,636
2024-03-04 2024-03-01 PlS Planned sale
1.5
Elliott Jeffrey Thomas

Chief Financial Officer

Officer
2,412 -18.1%
59.32
US$143,080 		2,412 -18.1% 59.32 US$143,080
2024-03-04 2024-03-01 PlS Planned sale
2.9
Cunningham Everett

Chief Commercial Officer

Officer
2,412 -5.0%
59.32
US$143,080 		2,412 -5.0% 59.32 US$143,080
2024-03-04 2024-03-01 PlS Planned sale
Doyle James Edward
Non-Executive Director
2,000 -3.8%
57.50
US$115,000 		2,000 -3.8% 57.50 US$115,000
2024-03-04 2024-03-01 PlS Planned sale
Baranick Brian

Gen. Mgr., Precision Oncology

Officer
2,323 -14.1%
59.32
US$137,800 		2,323 -14.1% 59.32 US$137,800
2024-03-04 2024-03-01 PlS Planned sale
LEVANGIE DANIEL J
Non-Executive Director
5,000 -17.9%
57.50
US$287,500 		5,000 -17.9% 57.50 US$287,500
2024-03-04 2024-03-01 PlS Planned sale
3.0
Condella Sarah

EVP, Human Resources

Officer
1,724 -2.2%
59.32
US$102,268 		1,724 -2.2% 59.32 US$102,268
2024-03-01 2024-03-01 PrS Proposed sale
2.9
Cunningham Everett

Officer

Officer
2,412
59.32
US$143,078 		2,412 59.32 US$143,078
2024-03-01 2024-03-01 PrS Proposed sale
Herriott James

Officer

Officer
862
59.32
US$51,133 		862 59.32 US$51,133
2024-03-01 2024-03-01 PrS Proposed sale
3.0
Condella Sarah

Officer

Officer
1,724
59.32
US$102,266 		1,724 59.32 US$102,266
2024-03-01 2024-03-01 PrS Proposed sale
1.5
Elliott Jeffrey Thomas

Officer

Officer
2,412
59.32
US$143,078 		2,412 59.32 US$143,078
2024-03-01 2024-03-01 PrS Proposed sale
ORVILLE JACOB A

Officer

Officer
2,154
59.32
US$127,773 		2,154 59.32 US$127,773
2024-03-01 2024-03-01 PrS Proposed sale
Baranick Brian

Officer

Officer
2,323
59.32
US$137,798 		2,323 59.32 US$137,798
2024-03-01 2024-03-01 PrS Proposed sale
1.8
Conroy Kevin T

Officer; Director

Executive Director
8,271
59.32
US$490,628 		8,271 59.32 US$490,628
2024-03-01 2024-03-01 PrS Proposed sale
Doyle James Edward

Director

Non-Executive Director
2,000
57.50
US$115,000 		2,000 57.50 US$115,000
2024-03-01 2024-03-01 PrS Proposed sale
LEVANGIE DANIEL J

Director

Non-Executive Director
5,000
57.50
US$287,500 		5,000 57.50 US$287,500
2024-02-28 2024-02-27 PlS Planned sale
3.0
Condella Sarah

EVP, Human Resources

Officer
1,880 -2.5%
56.89
US$106,953 		1,880 -2.5% 56.89 US$106,953
2024-02-28 2024-02-27 PlS Planned sale
ORVILLE JACOB A

General Manager, Screening

Officer
1,879 -13.8%
56.89
US$106,896 		1,879 -13.8% 56.89 US$106,896
2024-02-28 2024-02-27 PlS Planned sale
Baranick Brian

Gen. Mgr., Precision Oncology

Officer
2,027 -14.8%
56.89
US$115,316 		2,027 -14.8% 56.89 US$115,316
2024-02-28 2024-02-27 PlS Planned sale
Herriott James

General Counsel

Officer
784 -8.8%
56.89
US$44,602 		784 -8.8% 56.89 US$44,602
2024-02-28 2024-02-27 PlS Planned sale
1.8
Conroy Kevin T

President and CEO

Executive Director
6,263 -0.5%
56.89
US$356,302 		6,263 -0.5% 56.89 US$356,302
2024-02-28 2024-02-27 PlS Planned sale
2.9
Cunningham Everett

Chief Commercial Officer

Officer
3,648 -7.8%
56.89
US$207,535 		3,648 -7.8% 56.89 US$207,535
2024-02-28 2024-02-27 PlS Planned sale
1.5
Elliott Jeffrey Thomas

Chief Financial Officer

Officer
2,710 -25.2%
56.89
US$154,172 		2,710 -25.2% 56.89 US$154,172
Explore more

More insider trading research around Exact Sciences Corp

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America